ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	27887982	A594V	UL97	UL97	Cytomegalovirus infections	D R C L	View
2	27887982	A614S	UL54	UL54	Cytomegalovirus infections	R C L	View
3	27887982	A688V	UL54	UL54	Cytomegalovirus infections	R C L	View
4	27887982	A885T	UL54	UL54	Cytomegalovirus infections	R C L	View
5	27887982	C592G	UL97	UL97	Cytomegalovirus infections	D R C L	View
6	27887982	C603W	UL97	UL97	Cytomegalovirus infections	D R C L	View
7	27887982	F669L	UL54	UL54	Cytomegalovirus infections	R C L	View
8	27887982	G874R	UL54	UL54	Cytomegalovirus infections	R C L	View
9	27887982	I244V	UL97	UL97	Cytomegalovirus infections	R C L	View
10	27887982	885insS	UL54	UL54	Cytomegalovirus infections	R C L	View
11	27887982	L126Q	UL97	UL97	Cytomegalovirus infections	R C L	View
12	27887982	L595W	UL97	UL97	Cytomegalovirus infections	D R C L	View
13	27887982	L890F	UL54	UL54	Cytomegalovirus infections	R C L	View
14	27887982	L957F	UL54	UL54	Cytomegalovirus infections	D R C L	View
15	27887982	N510S	UL97	UL97	Cytomegalovirus infections	R C L	View
16	27887982	N685S	UL54	UL54	Cytomegalovirus infections	R C L	View
17	27887982	N68D	UL97	UL97	Cytomegalovirus infections	R C L	View
18	27887982	N898D	UL54	UL54	Cytomegalovirus infections	R C L	View
19	27887982	P247S	UL97	UL97	Cytomegalovirus infections	R C L	View
20	27887982	P522S	UL54	UL54	Cytomegalovirus infections	D R C L	View
21	27887982	Q19E	UL97	UL97	Cytomegalovirus infections	R C L	View
22	27887982	S108N	UL97	UL97	Cytomegalovirus infections	R C L	View
23	27887982	S655L	UL54	UL54	Cytomegalovirus infections	R C L	View
24	27887982	S676G	UL54	UL54	Cytomegalovirus infections	R C L	View
25	27887982	S897L	UL54	UL54	Cytomegalovirus infections	R C L	View

Contents
Description

The table shows all curated mutation sites of HCMV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.